How Peripheral Artery Disease Can Sneak Up on You
Peripheral artery disease takes hold over time, sometimes without people knowing it. Here are the subtle symptoms to look for. (Source: WebMD Health)
Source: WebMD Health - November 15, 2021 Category: Consumer Health News Source Type: news

Do I Really Need Surgery for Peripheral Artery Disease?
Find out when someone with peripheral artery disease (PAD) might need surgery or another procedure to help treat it. (Source: WebMD Health)
Source: WebMD Health - November 15, 2021 Category: Consumer Health News Source Type: news

Ease Your Leg and Arm Pain From Peripheral Artery Disease
Leg pain is a top symptom of peripheral artery disease. Here are tips on how to manage it and to ease your pain. (Source: WebMD Health)
Source: WebMD Health - November 11, 2021 Category: Consumer Health News Source Type: news

New Research Finds Challenges in Symptom Recognition and Diagnostic Testing can impact Patient Satisfaction for People with Vascular Disease
- One in four physicians surveyed feel the "lack of technology or equipment to make an accurate diagnosis of coronary artery disease and peripheral artery disease" is a key obstacle to an accurate diagnosis (Source: Abbott.com)
Source: Abbott.com - November 10, 2021 Category: Pharmaceuticals Source Type: news

Peripheral Artery Disease: What Your Family and Friends Should Know
If you have peripheral artery disease (PAD), these tips will help you get the support you want from your loved ones. (Source: WebMD Health)
Source: WebMD Health - November 9, 2021 Category: Consumer Health News Source Type: news

Skin Care Tips for People With PAD, From a Dermatologist
Peripheral artery disease (PAD) can cause changes and discomfort to the skin on your legs and feet. Here’s how to manage the symptoms and what to look out for. (Source: WebMD Health)
Source: WebMD Health - November 8, 2021 Category: Consumer Health News Source Type: news

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Peripheral Artery Disease (PAD) and Sleep
Peripheral artery disease (PAD) can lead to sleep problems. Learn more about the ways PAD may affect your sleep. (Source: WebMD Health)
Source: WebMD Health - October 28, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Reports Q3 2021 Results
New Brunswick, N.J. (October 19, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of our stakeholders, ...
Source: Johnson and Johnson - October 19, 2021 Category: Pharmaceuticals Tags: Financial Source Type: news

Peripheral Artery Disease: Common, and Here's How to Spot It
Title: Peripheral Artery Disease: Common, and Here ' s How to Spot ItCategory: Health NewsCreated: 9/29/2021 12:00:00 AMLast Editorial Review: 9/29/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 29, 2021 Category: Cardiology Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the U.S. F...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Looks Like Acrocyanosis?
Discussion Acrocyanosis is a peripheral vascular disease where the skin and mucous membranes have a persistent, painless, deep-bluish color due to decreased oxygenated blood which usually is benign. The deoxygenated blood can be due to a central cause such as cyanotic congenital heart disease or localized problems often due to vasospasm. Hands and feet are the most common areas affected. It is thought that there is “…vasospasm of the cutaneous arteries, and arterioles along with compensatory dilatation in the capillary and post capillary venules caus[ing] cyanosis and sweating.” Palms and soles may or may...
Source: PediatricEducation.org - September 27, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

High cholesterol symptoms: How long are your toenails? A warning of artery disease
HIGH cholesterol is a health hazard, as the fatty material embeds along artery walls, narrowing blood vessel passageways and restricting blood flow. If you have too much, peripheral artery disease can develop. (Source: Daily Express - Health)
Source: Daily Express - Health - September 23, 2021 Category: Consumer Health News Source Type: news

Risk Factors ID'd for Lower-Limb Amputation for PAD in Urban Areas
FRIDAY, Aug. 27, 2021 -- Lower socioeconomic status and Black race are associated with higher rates of major lower-extremity amputation in patients with peripheral artery disease, even in metropolitan areas, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 27, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in p...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news